Tirzepatide — Dual GIP/GLP-1 Receptor Agonist
Tirzepatide is a dual-acting peptide targeting both GIP and GLP-1 receptors. This innovative compound enables researchers to study the synergistic effects of simultaneous incretin receptor activation, a critical area of metabolic research.
Research Applications
- Dual incretin receptor activation studies
- Comparative metabolic research
- Body composition analysis protocols
- Glycemic control mechanism research
Specifications
- Purity: ≥99% (HPLC verified)
- Form: Lyophilized powder
- Storage: -20°C recommended
- For research use only
Reviews
There are no reviews yet.